ID   NSE3_HUMAN              Reviewed;         304 AA.
AC   Q96MG7; Q8IW16; Q8TEI6; Q9H214;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   07-APR-2021, entry version 153.
DE   RecName: Full=Non-structural maintenance of chromosomes element 3 homolog;
DE            Short=Non-SMC element 3 homolog;
DE   AltName: Full=Hepatocellular carcinoma-associated protein 4;
DE   AltName: Full=MAGE-G1 antigen;
DE   AltName: Full=Melanoma-associated antigen G1;
DE   AltName: Full=Necdin-like protein 2;
GN   Name=NSMCE3 {ECO:0000312|HGNC:HGNC:7677}; Synonyms=HCA4, MAGEG1, NDNL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Dong X.-Y., Chen W.-F.;
RT   "Identification of genes in the chromosome X that are differentially
RT   expressed in hepatocellular carcinoma.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Lung, Spleen, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 85-304.
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 189-288.
RC   TISSUE=Testis;
RA   Lucas S., Boon T.;
RT   "Identification of new genes of the MAGE family.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=11782285; DOI=10.1186/1471-2156-2-22;
RA   Chibuk T.K., Bischof J.M., Wevrick R.;
RT   "A necdin/MAGE-like gene in the chromosome 15 autism susceptibility region:
RT   expression, imprinting, and mapping of the human and mouse orthologues.";
RL   BMC Genet. 2:22-22(2001).
RN   [7]
RP   SUBCELLULAR LOCATION, INTERACTION WITH NSMCE1 AND SMC6, AND IDENTIFICATION
RP   IN THE SMC5-SMC6 COMPLEX.
RX   PubMed=18086888; DOI=10.1128/mcb.00767-07;
RA   Taylor E.M., Copsey A.C., Hudson J.J., Vidot S., Lehmann A.R.;
RT   "Identification of the proteins, including MAGEG1, that make up the human
RT   SMC5-6 protein complex.";
RL   Mol. Cell. Biol. 28:1197-1206(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57 AND SER-64, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INTERACTION WITH EID3 AND NSMCE1, AND MUTAGENESIS OF MET-180; ILE-181;
RP   LEU-185; PHE-266 AND VAL-270.
RX   PubMed=21364888; DOI=10.1371/journal.pone.0017270;
RA   Hudson J.J., Bednarova K., Kozakova L., Liao C., Guerineau M., Colnaghi R.,
RA   Vidot S., Marek J., Bathula S.R., Lehmann A.R., Palecek J.;
RT   "Interactions between the Nse3 and Nse4 components of the SMC5-6 complex
RT   identify evolutionarily conserved interactions between MAGE and EID
RT   Families.";
RL   PLoS ONE 6:E17270-E17270(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-60 AND SER-64, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.92 ANGSTROMS) OF 78-294 IN COMPLEX WITH NSMCE1,
RP   FUNCTION, INTERACTION WITH NSMCE1; NSMCE4A AND PJA1, AND MUTAGENESIS OF
RP   96-LEU-LEU-97.
RX   PubMed=20864041; DOI=10.1016/j.molcel.2010.08.029;
RA   Doyle J.M., Gao J., Wang J., Yang M., Potts P.R.;
RT   "MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.";
RL   Mol. Cell 39:963-974(2010).
RN   [16]
RP   VARIANTS LICS LEU-209 AND PHE-264, CHARACTERIZATION OF VARIANTS LICS
RP   LEU-209 AND PHE-264, INVOLVEMENT IN LICS, FUNCTION, SUBUNIT, AND
RP   INTERACTION WITH NSMCE1 AND NSMCE4.
RX   PubMed=27427983; DOI=10.1172/jci82890;
RA   van der Crabben S.N., Hennus M.P., McGregor G.A., Ritter D.I.,
RA   Nagamani S.C., Wells O.S., Harakalova M., Chinn I.K., Alt A., Vondrova L.,
RA   Hochstenbach R., van Montfrans J.M., Terheggen-Lagro S.W., van Lieshout S.,
RA   van Roosmalen M.J., Renkens I., Duran K., Nijman I.J., Kloosterman W.P.,
RA   Hennekam E., Orange J.S., van Hasselt P.M., Wheeler D.A., Palecek J.J.,
RA   Lehmann A.R., Oliver A.W., Pearl L.H., Plon S.E., Murray J.M.,
RA   van Haaften G.;
RT   "Destabilized SMC5/6 complex leads to chromosome breakage syndrome with
RT   severe lung disease.";
RL   J. Clin. Invest. 126:2881-2892(2016).
CC   -!- FUNCTION: Component of the SMC5-SMC6 complex, a complex involved in
CC       repair of DNA double-strand breaks by homologous recombination
CC       (PubMed:20864041, PubMed:27427983). The complex may promote sister
CC       chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin
CC       complex to double-strand breaks. The complex is required for telomere
CC       maintenance via recombination in ALT (alternative lengthening of
CC       telomeres) cell lines and mediates sumoylation of shelterin complex
CC       (telosome) components which is proposed to lead to shelterin complex
CC       disassembly in ALT-associated PML bodies (APBs). In vitro enhances
CC       ubiquitin ligase activity of NSMCE1. Proposed to act through
CC       recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at
CC       the E3:substrate complex (PubMed:20864041). May be a growth suppressor
CC       that facilitates the entry of the cell into cell cycle arrest (By
CC       similarity). {ECO:0000250|UniProtKB:Q9CPR8,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:27427983}.
CC   -!- SUBUNIT: Component of the SMC5-SMC6 complex which consists at least of
CC       SMC5, SMC6, NSMCE2, NSMCE1, NSMCE4A or EID3 and NSMCE3. NSMCE1, NSMCE4A
CC       or EID3 and NSMCE3 probably form a subcomplex that bridges the head
CC       domains of the SMC5:SMC6 heterodimer (PubMed:18086888). Interacts with
CC       PJA1 (PubMed:20864041). Interacts with E2F1 (via C-terminus) (By
CC       similarity). Interacts with NGFR (via C-terminus) (By similarity).
CC       Interacts with NSMCE1 (PubMed:18086888, PubMed:21364888,
CC       PubMed:20864041, PubMed:27427983). Interacts with NSMCE4
CC       (PubMed:20864041, PubMed:27427983). Interacts with SMC6
CC       (PubMed:18086888). Interacts with EID3 (PubMed:21364888).
CC       {ECO:0000250|UniProtKB:Q9CPR8, ECO:0000269|PubMed:18086888,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:21364888,
CC       ECO:0000269|PubMed:27427983}.
CC   -!- INTERACTION:
CC       Q96MG7; Q8N140: EID3; NbExp=5; IntAct=EBI-2557356, EBI-744483;
CC       Q96MG7; Q8WV22: NSMCE1; NbExp=19; IntAct=EBI-2557356, EBI-2557372;
CC       Q96MG7; Q9NXX6: NSMCE4A; NbExp=4; IntAct=EBI-2557356, EBI-2557393;
CC       Q96MG7; Q8NG27: PJA1; NbExp=3; IntAct=EBI-2557356, EBI-714606;
CC       Q96MG7; Q96SB8: SMC6; NbExp=5; IntAct=EBI-2557356, EBI-605415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000269|PubMed:18086888}. Chromosome, telomere
CC       {ECO:0000305|PubMed:18086888}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11782285}.
CC   -!- DISEASE: Lung disease, immunodeficiency, and chromosome breakage
CC       syndrome (LICS) [MIM:617241]: An autosomal recessive chromosome
CC       breakage syndrome associated with severe, fatal lung disease in early
CC       childhood, following viral pneumonia. LICS is characterized by combined
CC       T and B-cell immunodeficiency. Some patients may have mild dysmorphic
CC       features. {ECO:0000269|PubMed:27427983}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB84964.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF490510; AAM08357.1; -; mRNA.
DR   EMBL; AK056957; BAB71325.1; -; mRNA.
DR   EMBL; BC041166; AAH41166.2; -; mRNA.
DR   EMBL; BC053999; AAH53999.1; -; mRNA.
DR   EMBL; AK074138; BAB84964.1; ALT_FRAME; mRNA.
DR   EMBL; AF320911; AAG38607.1; -; Genomic_DNA.
DR   CCDS; CCDS10023.1; -.
DR   RefSeq; NP_619649.1; NM_138704.3.
DR   PDB; 5HVQ; X-ray; 2.92 A; D=78-294.
DR   PDB; 5WY5; X-ray; 2.92 A; B=78-294.
DR   PDBsum; 5HVQ; -.
DR   PDBsum; 5WY5; -.
DR   SMR; Q96MG7; -.
DR   BioGRID; 121094; 26.
DR   ComplexPortal; CPX-5992; SMC5-SMC6 SUMO ligase complex, EID3 variant.
DR   ComplexPortal; CPX-6086; SMC5-SMC6 SUMO ligase complex, NSE4EA variant.
DR   IntAct; Q96MG7; 11.
DR   STRING; 9606.ENSP00000330694; -.
DR   iPTMnet; Q96MG7; -.
DR   PhosphoSitePlus; Q96MG7; -.
DR   BioMuta; NSMCE3; -.
DR   DMDM; 46396494; -.
DR   EPD; Q96MG7; -.
DR   jPOST; Q96MG7; -.
DR   MassIVE; Q96MG7; -.
DR   MaxQB; Q96MG7; -.
DR   PaxDb; Q96MG7; -.
DR   PeptideAtlas; Q96MG7; -.
DR   PRIDE; Q96MG7; -.
DR   ProteomicsDB; 77353; -.
DR   Antibodypedia; 41882; 49 antibodies.
DR   Ensembl; ENST00000332303; ENSP00000330694; ENSG00000185115.
DR   Ensembl; ENST00000631973; ENSP00000487893; ENSG00000282130.
DR   GeneID; 56160; -.
DR   KEGG; hsa:56160; -.
DR   UCSC; uc001zco.4; human.
DR   CTD; 56160; -.
DR   DisGeNET; 56160; -.
DR   GeneCards; NSMCE3; -.
DR   HGNC; HGNC:7677; NSMCE3.
DR   HPA; ENSG00000185115; Low tissue specificity.
DR   MalaCards; NSMCE3; -.
DR   MIM; 608243; gene.
DR   MIM; 617241; phenotype.
DR   neXtProt; NX_Q96MG7; -.
DR   OpenTargets; ENSG00000185115; -.
DR   PharmGKB; PA31480; -.
DR   VEuPathDB; HostDB:ENSG00000185115.4; -.
DR   eggNOG; KOG4562; Eukaryota.
DR   GeneTree; ENSGT00940000163627; -.
DR   HOGENOM; CLU_039582_2_0_1; -.
DR   InParanoid; Q96MG7; -.
DR   OMA; YPTKKHL; -.
DR   OrthoDB; 1195799at2759; -.
DR   PhylomeDB; Q96MG7; -.
DR   TreeFam; TF328505; -.
DR   PathwayCommons; Q96MG7; -.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   BioGRID-ORCS; 56160; 613 hits in 1005 CRISPR screens.
DR   EvolutionaryTrace; Q96MG7; -.
DR   GenomeRNAi; 56160; -.
DR   Pharos; Q96MG7; Tbio.
DR   PRO; PR:Q96MG7; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q96MG7; protein.
DR   Bgee; ENSG00000185115; Expressed in islet of Langerhans and 210 other tissues.
DR   Genevisible; Q96MG7; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0030915; C:Smc5-Smc6 complex; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0072711; P:cellular response to hydroxyurea; IMP:UniProtKB.
DR   GO; GO:0071478; P:cellular response to radiation; IMP:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IMP:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.1200; -; 1.
DR   Gene3D; 1.10.10.1210; -; 1.
DR   InterPro; IPR037445; MAGE.
DR   InterPro; IPR041898; MAGE_WH1.
DR   InterPro; IPR041899; MAGE_WH2.
DR   InterPro; IPR002190; MHD_dom.
DR   PANTHER; PTHR11736; PTHR11736; 1.
DR   Pfam; PF01454; MAGE; 1.
DR   SMART; SM01373; MAGE; 1.
DR   PROSITE; PS50838; MAGE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosome; Cytoplasm; Disease variant; DNA damage;
KW   DNA recombination; DNA repair; Growth regulation; Nucleus; Phosphoprotein;
KW   Reference proteome; Telomere; Tumor antigen; Ubl conjugation pathway.
FT   CHAIN           1..304
FT                   /note="Non-structural maintenance of chromosomes element 3
FT                   homolog"
FT                   /id="PRO_0000156733"
FT   DOMAIN          85..285
FT                   /note="MAGE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00127"
FT   REGION          78..304
FT                   /note="Interaction with NSMCE1"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   VARIANT         209
FT                   /note="P -> L (in LICS; creates novel endoproteolytic
FT                   cleavage sites compared to wild-type; loss of interaction
FT                   with NSMCE4; loss of interaction with NSMCE1;
FT                   dbSNP:rs886037827)"
FT                   /evidence="ECO:0000269|PubMed:27427983"
FT                   /id="VAR_078021"
FT   VARIANT         264
FT                   /note="L -> F (in LICS; no loss of protein stability; loss
FT                   of interaction with NSMCE4; decreased interaction with
FT                   NSMCE1; decreased association with the SMC5-SMC6 complex;
FT                   decreased DNA repair; dbSNP:rs199905054)"
FT                   /evidence="ECO:0000269|PubMed:27427983"
FT                   /id="VAR_078022"
FT   MUTAGEN         96..97
FT                   /note="LL->AA: Decreases interaction with NSMCE1, no effect
FT                   on interaction with NSMCE4A, abolishes in vitro promotion
FT                   of NSMCE1 ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:20864041"
FT   MUTAGEN         180
FT                   /note="M->A: Abolishes interaction with EID3."
FT                   /evidence="ECO:0000269|PubMed:21364888"
FT   MUTAGEN         181
FT                   /note="I->A: Abolishes interaction with EID3."
FT                   /evidence="ECO:0000269|PubMed:21364888"
FT   MUTAGEN         185
FT                   /note="L->A: Abolishes interaction with EID3."
FT                   /evidence="ECO:0000269|PubMed:21364888"
FT   MUTAGEN         266
FT                   /note="F->A: Abolishes interaction with EID3."
FT                   /evidence="ECO:0000269|PubMed:21364888"
FT   MUTAGEN         270
FT                   /note="V->A: Abolishes interaction with EID3."
FT                   /evidence="ECO:0000269|PubMed:21364888"
FT   HELIX           82..102
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           108..114
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           117..122
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           123..138
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   STRAND          140..146
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   STRAND          150..156
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   TURN            166..169
FT                   /evidence="ECO:0007744|PDB:5HVQ"
FT   HELIX           174..188
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   TURN            189..191
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           195..204
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           220..230
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   STRAND          232..236
FT                   /evidence="ECO:0007744|PDB:5HVQ"
FT   STRAND          247..249
FT                   /evidence="ECO:0007744|PDB:5HVQ"
FT   HELIX           252..255
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           260..271
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   STRAND          275..277
FT                   /evidence="ECO:0007744|PDB:5WY5"
FT   HELIX           278..293
FT                   /evidence="ECO:0007744|PDB:5WY5"
SQ   SEQUENCE   304 AA;  34308 MW;  C00E2FB2D2CCED7B CRC64;
     MLQKPRNRGR SGGQAERDRD WSHSGNPGAS RAGEDARVLR DGFAEEAPST SRGPGGSQGS
     QGPSPQGARR AQAAPAVGPR SQKQLELKVS ELVQFLLIKD QKKIPIKRAD ILKHVIGDYK
     DIFPDLFKRA AERLQYVFGY KLVELEPKSN TYILINTLEP VEEDAEMRGD QGTPTTGLLM
     IVLGLIFMKG NTIKETEAWD FLRRLGVYPT KKHLIFGDPK KLITEDFVRQ RYLEYRRIPH
     TDPVDYEFQW GPRTNLETSK MKVLKFVAKV HNQDPKDWPA QYCEALADEE NRARPQPSGP
     APSS
//
